Chewy CHWY has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 7 | 7 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 5 | 5 | 0 | 0 |
| 2M Ago | 0 | 2 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $24.12, a high estimate of $35.00, and a low estimate of $16.00. Marking an increase of 12.5%, the current average surpasses the previous average price target of $21.44.
Diving into Analyst Ratings: An In-Depth Exploration
An in-depth analysis of recent analyst actions unveils how financial experts perceive Chewy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jonathan Elias | Guggenheim | Raises | Buy | $32.00 | $25.00 |
| Seth Basham | Wedbush | Raises | Outperform | $35.00 | $28.00 |
| David Bellinger | Mizuho | Raises | Neutral | $20.00 | $18.00 |
| Mark Mahaney | Evercore ISI Group | Raises | In-Line | $22.00 | $19.00 |
| Lee Horowitz | Deutsche Bank | Raises | Hold | $20.00 | $18.00 |
| Doug Anmuth | JP Morgan | Raises | Overweight | $28.00 | $22.00 |
| Rick Patel | Raymond James | Raises | Outperform | $24.00 | $19.00 |
| Michael Lasser | UBS | Raises | Neutral | $21.00 | $19.00 |
| Seth Basham | Wedbush | Raises | Outperform | $28.00 | $25.00 |
| Peter Keith | Piper Sandler | Raises | Neutral | $22.00 | $16.00 |
| Lauren Schenk | Morgan Stanley | Raises | Overweight | $28.00 | $27.00 |
| Anna Andreeva | Needham | Raises | Buy | $30.00 | $25.00 |
| Seth Basham | Wedbush | Maintains | Outperform | $25.00 | $25.00 |
| Rick Patel | Raymond James | Lowers | Outperform | $19.00 | $20.00 |
| Steven Zaccone | Citigroup | Lowers | Neutral | $16.00 | $18.00 |
| Peter Keith | Piper Sandler | Lowers | Neutral | $16.00 | $19.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Chewy. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Chewy compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Chewy's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Chewy's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Chewy analyst ratings.
Discovering Chewy: A Closer Look
Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Chewy's Financial Performance
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Chewy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 3.12% as of 30 April, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Chewy's net margin is impressive, surpassing industry averages. With a net margin of 2.32%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Chewy's ROE stands out, surpassing industry averages. With an impressive ROE of 11.6%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Chewy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.09% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Chewy's debt-to-equity ratio is below the industry average at 0.81, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyst Ratings: What Are They?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
